Nicotine and Tobacco Message Framing to Change Smoking Behavior in Diverse Groups of Young Adult Smokers
Purpose
This clinical trial evaluates the effect of message framing on smoking behaviors among lesbian, gay, bisexual, transgender, queer (LGBTQ+) young adults who use nicotine and/or tobacco. Tobacco regulation has contributed to a steady decline in tobacco products designed to be smoked (combustible), but there has been an increase in the use of new tobacco products, such as electronic nicotine delivery systems (ENDS). The use of more than one tobacco product (polytobacco) is high in LGBTQ+ populations. Both LGBTQ+ people and people who engage in polytobacco use are less likely to view tobacco as harmful, which may reinforce tobacco use. Message framing includes culturally targeted messages to communicate the absolute risks (AR) and relative risks (RR) of polytobacco use. Using message framing may increase quit rates or change smoking behaviors in LGBTQ+ young adults who use nicotine and/or tobacco products.
Condition
- Tobacco-Related Carcinoma
Eligibility
- Eligible Ages
- Between 18 Years and 35 Years
- Eligible Genders
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- 18-35 years old - Self-identify as LGBTQ+ - Able to speak English fluently - An ever user of ENDS and combustible tobacco who currently use ENDS, combustible cigarettes, or both ENDS and combustible cigarettes - Currently reside in the United States (US) - Have a mobile phone through a U.S. carrier with MMS messaging and can send and receive text messages for study participation - Access to the internet with Zoom capabilities
Exclusion Criteria
- Have a landline or Voice Over Internet Protocol (VOIP) phone number
Study Design
- Phase
- N/A
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel Assignment
- Primary Purpose
- Prevention
- Masking
- Single (Participant)
- Masking Description
- Participants are blinded to their randomization category (absolute risks, relative risks, or control)
Arm Groups
Arm | Description | Assigned Intervention |
---|---|---|
Experimental Arm I (Absolute Risk messages) |
Participants receive AR anti-polytobacco MMS messages TIW and a check-in text message QW for a total of 6 weeks. Participants also receive smoking cessation resources via email during follow up. |
|
Experimental Arm II (Relative Risk messages) |
Participants receive RR anti-polytobacco MMS messages TIW and a check-in text message QW for a total of 6 weeks. Participants also receive smoking cessation resources via email during follow up. |
|
Active Comparator Arm III (control messages) |
Participants receive control MMS messages on health risks of UV/sun exposure TIW and a check-in text message QW for a total of 6 weeks. Participants also receive smoking cessation resources via email during follow up. |
|
Recruiting Locations
Columbus, Ohio 43210
More Details
- NCT ID
- NCT06644664
- Status
- Recruiting
- Sponsor
- Ohio State University Comprehensive Cancer Center
Study Contact
The Ohio State University Comprehensive Cancer Center800-293-5066
OSUCCCClinicaltrials@osumc.edu
Detailed Description
PRIMARY OBJECTIVES: I. Assess the feasibility of delivering mobile multimedia messaging (MMS) anti-tobacco messages developed in the K99 to LGBT young adults via texting. II. Estimate effect sizes of exposure to anti-tobacco messages on risk perceptions and tobacco use over time. OUTLINE: Participants are randomized to 1 of 3 arms. ARM I: Participants receive AR anti-polytobacco MMS messages 3 times a week (TIW) and a check-in text message once a week (QW) for a total of 6 weeks. ARM II: Participants receive RR anti-polytobacco MMS messages TIW and a check-in text message QW for a total of 6 weeks. ARM III: Participants receive control MMS messages on health risks of ultraviolet (UV)/sun exposure TIW and a check-in text message QW for a total of 6 weeks. All participants also receive smoking cessation resources via email during follow up. After completion of study intervention, participants are followed up at 6 and 12 weeks.